Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Idiopathic Nephrotic Syndrome | Kisho | Kisho

Back to Idiopathic Nephrotic Syndrome

Idiopathic Nephrotic Syndrome — NIH Grants & Funding

Active and recent NIH-funded research on Idiopathic Nephrotic Syndrome. Data from NIH RePORTER, last 36 months.

MONDO:0018170

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Idiopathic Nephrotic Syndrome has active NIH research funding with 6 funded grants totaling $7.0M.

6funded grants from NIH

Portfolio: $1.3MCumulative: $7.0M3 active3 completed10 PIs6 institutions

By Research Theme

Basic Science

Clinical

Gene/Cell Therapy

Biomarker / Dx

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$2.6M

FY22

$2.0M

FY23

$2.1M

FY24

$322K

FY25

By Funding Mechanism

K08

R01

R21

RC2

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Idiopathic Nephrotic Syndrome. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.

Epidemiology / Natural HistoryPublished, Not NIH-Funded

18 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for idiopathic nephrotic syndrome. Existing research activity suggests this may be a viable area for grant applications.

Adjacent Research(4 grants)

These grants mention Idiopathic Nephrotic Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(4)

OtherR01Active

Pathobiology of autoimmune-mediated diffuse podocytopathy

Weins, Astrid·BRIGHAM AND WOMEN'S HOSPITAL·BOSTON, MA

$708,681 (FY2025)

NIH RePORTER

OtherR01Active

REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME

Gbadegesin, Rasheed·DUKE UNIVERSITY·DURHAM, NC

$615,845 (FY2026)

NIH RePORTER

OtherR01Active

Role of LRP1 in Podocyte Biology

Ishibe, Shuta·YALE UNIVERSITY·NEW HAVEN, CT

$439,421 (FY2025)

NIH RePORTER

OtherF32Completed

Discovering the Consequences of Genetic Variation in Nephrin on Kidney Diseases and Traits in Biobank Populations

Banerji, Adrian·BOSTON CHILDREN'S HOSPITAL·BOSTON, MA

$11,901 (FY2025)

NIH RePORTER

Kisho

Idiopathic Nephrotic Syndrome — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(4 grants)

Other(4)

Pathobiology of autoimmune-mediated diffuse podocytopathy

REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME

Role of LRP1 in Podocyte Biology

Discovering the Consequences of Genetic Variation in Nephrin on Kidney Diseases and Traits in Biobank Populations

Top Funded Institutions

Top Principal Investigators